Urinary type IV collagen as a predictor for the incidence of microalbuminuria in young patients with Type 1 diabetes

被引:8
作者
Morita, M. [1 ,2 ]
Hanai, K. [1 ]
Uchigata, Y. [1 ]
机构
[1] Tokyo Womens Med Univ, Sch Med, Ctr Diabet, Tokyo, Japan
[2] Shimane Univ, Fac Med, Dept Internal Med 1, Matsue, Shimane, Japan
关键词
TUBULAR BASEMENT-MEMBRANE; NATURAL-HISTORY; KIDNEY-DISEASE; RENAL-FUNCTION; NEPHROPATHY; ASSOCIATION; DECLINE; EPIDEMIOLOGY; PROGRESSION; EXPRESSION;
D O I
10.1111/dme.12317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo clarify whether urinary type IV collagen-to-creatinine ratio is a predictor for the incidence of microalbuminuria in patients with Type1 diabetes. MethodsA longitudinal observational cohort study was conducted; the subjects included normoalbuminuric patients diagnosed with Type1 diabetes before the age of 30years and who were less than 40years old at the start of the observation. In total, 225 patients were enrolled (age, meanSD: 255years; male: 32.9%). The endpoint was the incidence of microalbuminuria, defined as 30 mg/g Cr urinary albumin-to-creatinine ratio < 300 mg/g Cr. Patients were divided into two groups based on the median of urinary type IV collagen-to-creatinine ratio levels. ResultsDuring the median follow-up period of 8.8years (range 1.0-12.8years), 13 patients with high urinary type IV collagen-to-creatinine ratio progressed to microalbuminuria. Meanwhile, only one patient with low urinary type IV collagen-to-creatinine ratio reached the endpoint. Kaplan-Meier estimates for the time to reach the endpoint were significantly faster for patients with a high ratio than for those with a low ratio (log-rank test, P<0.001). In the multivariate Cox hazard analysis, the hazard ratio for patients with high vs. low urinary type IV collagen-to-creatinine ratio was 13.51 (95%CI 1.59-115.02, P=0.017). When urinary type IV collagen-to-creatinine ratio was treated as a continuous variable, logarithmically transformed urinary type IV collagen-to-creatinine ratio, but not baseline albumin-to-creatinine ratio, was independently associated with reaching the endpoint (hazard ratio19.23, 95%CI 1.53-242.30, P=0.022). ConclusionsUrinary typeIV collagen may be an important predictor for the incidence of microalbuminuria in young patients with Type1 diabetes.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [41] A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996
    Lammi, N.
    Taskinen, O.
    Moltchanova, E.
    Notkola, I-L.
    Eriksson, J. G.
    Tuomilehto, J.
    Karvonen, M.
    DIABETOLOGIA, 2007, 50 (07) : 1393 - 1400
  • [42] Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study
    Nielsen, S. E.
    Persson, F.
    Frandsen, E.
    Sugaya, T.
    Hess, G.
    Zdunek, D.
    Shjoedt, K. J.
    Parving, H-H.
    Rossing, P.
    DIABETIC MEDICINE, 2012, 29 (08) : E184 - E190
  • [43] META-REGRESSION OF RISK FACTORS FOR MICROALBUMINURIA IN TYPE 2 DIABETES
    Mongkolsomlit, Sirima
    Patumanond, Jayanton
    Tawichasri, Chamaiporn
    Komoltri, Chulalux
    Rawdaree, Petch
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2012, 43 (02) : 455 - 466
  • [44] Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study
    van der Velden, Anouk I. M.
    van den Berg, Bernard M.
    van den Born, B. J.
    Galenkamp, Henrike
    Ijpelaar, Daphne H. T.
    Rabelink, Ton J.
    BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (06)
  • [45] Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy
    Broedbaek, Kasper
    Henriksen, Trine
    Weimann, Allan
    Petersen, Morten
    Andersen, Jon T.
    Afzal, Shoaib
    Jimenez-Solem, Espen
    Persson, Frederik
    Parving, Hans-Henrik
    Rossing, Peter
    Poulsen, Henrik E.
    DIABETES CARE, 2011, 34 (05) : 1192 - 1198
  • [46] Incidence of Autoimmune Thyroid Disease in Patients with Type 1 Diabetes
    Unal, Edip
    Demiral, Meliha
    Ocal, Murat
    Baysal, Birsen
    Ozbek, Mehmet Nuri
    GUNCEL PEDIATRI-JOURNAL OF CURRENT PEDIATRICS, 2020, 18 (02): : 251 - 262
  • [47] Long-term Renal Outcomes of Patients With Type 1 Diabetes Mellitus and Microalbuminuria An Analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort
    de Boer, Ian H.
    Rue, Tessa C.
    Cleary, Patricia A.
    Lachin, John M.
    Molitch, Mark E.
    Steffes, Michael W.
    Sun, Wanjie
    Zinman, Bernard
    Brunzell, John D.
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (05) : 412 - 420
  • [48] Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes
    Helve, Jaakko
    Sund, Reijo
    Arffman, Martti
    Harjutsalo, Valma
    Groop, Per-Henrik
    Gronhagen-Riska, Carola
    Finne, Patrik
    DIABETES CARE, 2018, 41 (03) : 434 - 439
  • [49] Novel Urinary Protein Biomarkers Predicting the Development of Microalbuminuria and Renal Function Decline in Type 1 Diabetes
    Schlatzer, Daniela
    Maahs, David M.
    Chance, Mark R.
    Dazard, Jean-Eudes
    Li, Xiaolin
    Hazlett, Fred
    Rewers, Marian
    Snell-Bergeon, Janet K.
    DIABETES CARE, 2012, 35 (03) : 549 - 555
  • [50] A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996
    N. Lammi
    O. Taskinen
    E. Moltchanova
    I-L. Notkola
    J. G. Eriksson
    J. Tuomilehto
    M. Karvonen
    Diabetologia, 2007, 50 : 1393 - 1400